Menu

Raj Chakraborty: MajesTEC-9 Shows PFS and OS Benefit With Teclistamab Monotherapy vs PVD/Kd

Article |

devcaptain01 3mo ago
Raj Chakraborty: MajesTEC-9 Shows PFS and OS Benefit With Teclistamab Monotherapy vs PVD/Kd

Raj Chakraborty, Hematologist, Oncologist, Clinical Researcher at Herbert Irving Comprehensive Cancer Center, and Assistant Professor at...

Comments (0)

Newest

No comments yet.